Vivani Medical (VANI) Assets Average (2018 - 2026)
Vivani Medical (VANI) posted quarterly Assets Average of $40.9 million for Q1 2026, up 93.43% year-over-year from $21.1 million in Q1 2025, and up 26.86% quarter-over-quarter from $32.2 million in Q4 2025.
Vivani Medical (VANI) Assets Average (2018 - 2026) Analysis & Trends
Vivani Medical's Assets Average history runs 9 years deep, the most recent figure standing at $40.9 million for Q1 2026.
- In Q1 2026, Assets Average rose 93.43% year-over-year to $40.9 million; the TTM figure through Mar 2026 stood at $40.9 million (up 93.43% YoY), while the FY2025 annual figure was $40.5 million, down 7.33% from the prior year.
- Assets Average for Q1 2026 stood at $40.9 million, up from $32.2 million in the prior quarter.
- The five-year high for Assets Average was $67.1 million in Q2 2022, with the low at $14.8 million in Q2 2025.
- The 5-year median for Assets Average is $47.9 million (2023), against an average of $44.1 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average soared 126.93% in 2022, then plunged 70.98% in 2025.
- Vivani Medical's Assets Average stood at $54.1 million in 2022, then decreased by 8.35% to $49.6 million in 2023, then retreated by 14.79% to $42.2 million in 2024, then dropped by 23.7% to $32.2 million in 2025, then gained by 26.86% to $40.9 million in 2026.
- Business Quant data shows VANI's Assets Average at $40.9 million in Q1 2026, $32.2 million in Q4 2025, and $27.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 42.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.00 Mn |
| Mar 31, 2026 | 40.87 Mn |
| Dec 31, 2025 | 32.22 Mn |
| Sep 30, 2025 | 26.98 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Mar 31, 2025 | 21.13 Mn |
| Dec 31, 2024 | 42.23 Mn |
| Sep 30, 2024 | 45.56 Mn |
| Jun 30, 2024 | 51.01 Mn |
| Mar 31, 2024 | 49.79 Mn |
| Dec 31, 2023 | 49.56 Mn |
| Sep 30, 2023 | 56.46 Mn |
| Jun 30, 2023 | 52.09 Mn |
| Mar 31, 2023 | 47.86 Mn |
| Dec 31, 2022 | 54.08 Mn |
| Sep 30, 2022 | 61.34 Mn |
| Jun 30, 2022 | 67.09 Mn |
| Mar 31, 2022 | 37.00 Mn |
| Dec 31, 2021 | 39.54 Mn |
| Sep 30, 2021 | 74.77 Mn |